This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Metabolic Disorders
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
[[Image:Acid beta glucosidase.png|350px|right|thumb| Acid Beta Glucosidase, a Major Target for Gaucher Disease]] | [[Image:Acid beta glucosidase.png|350px|right|thumb| Acid Beta Glucosidase, a Major Target for Gaucher Disease]] | ||
| - | [[Metabolic Disorders]] broadly covers illnesses related to faulty carbohydrate metabolism, [[Amino Acid Metabolism]], organic acid metabolism, or lysosomal storage. | + | [[Metabolic Disorders]] broadly covers illnesses related to faulty carbohydrate metabolism, [[Amino Acid Metabolism|amino acid metabolism]], organic acid metabolism, or lysosomal storage. |
Articles in Proteopedia concerning metabolic disorders include: | Articles in Proteopedia concerning metabolic disorders include: | ||
Revision as of 13:23, 25 September 2010
Metabolic Disorders broadly covers illnesses related to faulty carbohydrate metabolism, amino acid metabolism, organic acid metabolism, or lysosomal storage.
Articles in Proteopedia concerning metabolic disorders include:
- Acid-beta-glucosidase
- ß-2 Microglobulin
- Protective Protein/Cathepsin A (PPCA)
- Protective Protein/Cathepsin A (PPCA) 2
- Treatment_of_Gaucher_disease
- Velaglucerase
To view other Proteopedia pages about diseases & drug targets, See: Pharmaceutical Drug Targets
